| Development group (N= 390,577) | Validation group (N= 105,030) | ||
---|---|---|---|---|
Variables | Fulfilled 3/3 criteria | Did not fulfill criteria | Fulfilled 3/3 criteria | Did not fulfill criteria |
(n= 223,023, 57.1%) | (n= 167,554, 42.9%) | (n= 60,205, 57.3%) | (n= 44,825, 42.7%) | |
Death, n | 221,167 | 154,512 | 59,763 | 40,712 |
Survival, n | 1,856 | 13,042 | 442 | 4,113 |
Sensitivity (95% CI) | 0.589 (0.587 to 0.590) | 0.595 (0.592 to 0.598) | ||
Specificity (95% CI) | 0.875 (0.870 to 0.881) | 0.903 (0.894 to 0.911) | ||
PPV (95% CI) | 0.992 (0.991 to 0.992) | 0.993 (0.992 to 0.993) | ||
NPV (95% CI) | 0.078 (0.077 to 0.079) | 0.092 (0.089 to 0.095) | ||
Area under the ROC curve (95% CI) | 0.851 (0.850 to 0.852) | 0.874 (0.872 to 0.876) |